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Citrobacter freundii AmpD is an intracellular 1,6-anhydro-N-
acetylmuramyl-L-alanine amidase involved in both peptidoglycan
recycling and β-lactamase induction. AmpD exhibits a strict
specificity for 1,6-anhydromuropeptides and requires zinc for
enzymic activity. The AmpD three-dimensional structure exhibits
a fold similar to that of another Zn2+ N-acetylmuramyl-L-alanine
amidase, the T7 lysozyme, and these two enzymes define a new
family of Zn-amidases which can be related to the eukaryotic
PGRP (peptidoglycan-recognition protein) domains. In an attempt
to assign the different zinc ligands and to probe the catalytic
mechanism of AmpD amidase, molecular modelling based on the
NMR structure and site-directed mutagenesis were performed.
Mutation of the two residues presumed to act as zinc ligands into
alanine (H34A and D164A) yielded inactive proteins which had
also lost their ability to bind zinc. By contrast, the active H154N
mutant retained the capacity to bind the metal ion. Three other
residues which could be involved in the AmpD catalytic mech-
anism have been mutated (Y63F, E116A, K162H and K162Q).
The E116A mutant was inactive, but on the basis of the mole-
cular modelling this residue is not directly involved in the catalytic
mechanism, but rather in the binding of the zinc by contributing
to the correct orientation of His-34. The K162H and K162Q
mutants retained very low activity (0.7 and 0.2% of the wild-
type activity respectively), whereas the Y63F mutant showed
16% of the wild-type activity. These three latter mutants exhibited
a good affinity for Zn ions and the substituted residues are pro-
bably involved in the binding of the substrate. We also describe
a new method for generating the N-acetylglucosaminyl-1,6-an-
hydro-N-acetylmuramyl-tripeptide AmpD substrate from purified
peptidoglycan by the combined action of two hydrolytic enzymes.
Key words: AmpD, β-lactamase induction, muropeptide, peptido-
glycan recycling, site-directed mutagenesis, zinc amidase.
INTRODUCTION
In the bacterial cell wall, the peptidoglycan or murein is a rigid
macropolymer surrounding the cytoplasmic membrane. Its re-
markable rigidity allows eubacteria to resist their high intracellular
osmotic pressure and confers to these micro-organisms their spe-
cific shape. The peptidoglycan is composed of glycan chains of
alternating units of GlcNAc (N-acetylglucosamine) and MurNAc
(N-acetylmuramic acid), which are cross-linked by short peptides.
In Gram-negative bacteria the peptides are usually L-alanyl-γ -D-
glutamyl-meso-diaminopimelyl-D-alanine and are linked to the
glycan via an amide bond between the MurNAc carboxyl group
and the L-Ala amino group of the tetrapeptide.
Cell growth as well as the separation of the daughter
cells during cellular division requires a continuous remodelling
of peptidoglycan achieved by specific hydrolases (autolytic en-
zymes), among which MurNAc-L-Ala amidases (N-acetylmu-
ramyl-L-alanine amidases) specifically cleave the amide bond
between the lactyl group of the MurNAc and the α-amino group
of the peptide bridge L-alanine.
In Escherichia coli and presumably most other Gram-negative
bacteria, like Citrobacter freundii and Enterobacter cloacae,
40–50% of the peptidoglycan is degraded at each generation
[1–3] and 90% of the degraded products are recycled. The
major recycled compound resulting from the combined action of
the periplasmic lytic transglycosylase and L,D-carboxypeptidase
Abbreviations used: MurNAc, N-acetylmuramic acid; GlcNAc, N-acetylglucosamine; MurNAc-L-Ala amidase, N-acetylmuramyl-L-alanine amidase;
GlcNAc-anhMurNAc-tripeptide, N-acetylglucosaminyl-1,6-anhydro-N-acetylmuramyl-tripeptide; anhMurNAc-tripeptide, anhydro-N-acetylmuramyl-tripep-
tide; Tm, melting temperature; MM, molecular mechanics.
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is GlcNAc-anhMurNAc-tripeptide (N-acetylglucosaminyl-1,6-
anhydro-N-acetylmuramyl-tripeptide), which is transported in
the cytoplasm by the AmpG permease [4,5]. It is then either direc-
tly cleaved by the cytoplasmic AmpD anhydroMurNAc L-Ala
amidase (anhydro-N-acetylmuramyl-L-alanine amidase) or first
converted into anhMurNAc-tripeptide (anhydro-N-acetylmura-
myl-tripeptide) by a cytosolic β-N-acetylglucosaminidase [6] and
subsequently hydrolysed by AmpD. Interestingly, AmpD has a
strict specificity for 1,6-anhydro muropeptides and therefore
does not hydrolyse the murein precursor molecules such as
UDP-MurNAc-pentapeptide (UDP-N-acetylmuramyl-L-alanyl-
γ -D-glutamyl-meso-diaminopimelyl-D-alanyl-D-alanine) also
present in the cytoplasm. Accordingly, AmpD does not interfere
with peptidoglycan biosynthesis and controls the level of the
recycled anhydromuropeptides in the cytoplasm. In Gram-
negative bacteria having an inducible AmpC β-lactamase, the
induction mechanism is directly linked to the relative cytoplasmic
levels of anhydro muropeptides and UDP-MurNAc-pentapeptide.
Inactivation of the ampD gene leads to constitutive β-lactamase
overproduction in C. freundii and Enterobacter cloacae [7,8].
The activity of the C. freundii AmpD amidase has been shown to
be Zn2+-dependent and its three-dimensional structure in solution
has been established [9].
Based on the NMR structure of C. freundii AmpD [9], the
amino acids predicted to be Zn2+ ligands of AmpD include His-
34, His-154 and Asp-164. Tyr-63 and Lys-162 are also involved
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Figure 1 Stereo view of the superimposition of AmpD and T7 lysozyme with their zinc ligands
AmpD is shown in light grey and T7 lysozyme in black. The zinc ion is represented as a sphere.
in the catalytic mechanism (Figure 1). This is in accordance with
another Zn2+ MurNAc-L-Ala amidase, the T7 lysozyme [10],
whose structure has been solved by X-ray crystallography at 2.2 Å
resolution and which exhibits a fold similar to that of AmpD,
although the two proteins share only 20% sequence identity.
A Blast search of sequence databases shows that AmpD
homologues are found in wide variety of micro-organisms, ran-
ging from viruses to Gram-negative (Enterobacter, Salmonella,
Pseudomonas) and Gram-positive (Bacillus, Staphylococcus)
bacteria, including the filamentous genera (Streptomyces). More-
over, sequence alignments showed similarities with some eu-
karyotic PGRP (peptidoglycan-recognition protein) domains,
suggesting similar substrate-binding sites, including zinc-binding
and other residues essential for hydrolytic activity [9,11–13]. In
the present study, we constructed, by molecular mechanics (MM)
and dynamics, the complexes between AmpD and its substrate
(anhMurNAc-tripeptide) and between AmpD and the MurNAc-
tripeptide. Simultaneously, we investigated the AmpD active site
by site-directed mutagenesis.
MATERIALS AND METHODS
Plasmid constructions and mutagenesis
The wild-type C. freundii ampD gene was cloned into the expres-
sion vector pET-9a [14] by PCR [15] with primers D#1 (5′-
TAACATATGTTGTTAGACGAGGGCTGGCTG-3′) and D#2
(5′-AATGGATCCTGTAAACAGCGTCATGTCATC-3′) and
plasmid pCJ1 as a DNA template [5] and the source of the
C. freundii ampD gene. Amplification yielded a DNA fragment
containing the entire ampD coding sequence flanked on the 5′ and
3′ ends by the NdeI and BamHI restriction sites, respectively. This
PCR fragment was cloned into PCR-ScriptTM to give pCIP 251.
The DNA sequence of the insert was checked for mutations by
sequencing both strands according to standard procedures [16].
Next pCIP 251 was digested by NdeI and BamHI restriction
enzymes and ampD was cloned as an NdeI–BamHI fragment into
pET-9a (Novagen) to yield pCIP 252. In this construct, ampD is
under the control of the T7 promoter and inducible by isopropyl
β-D-thiogalactoside.
Production of the ampD gene in which the mutations had been
introduced was carried out using the QuikChangeTM site-directed
mutagenesis kit (Stratagene) with pCIP 251 as a template for
PCR reactions. Reactions conditions were 5 min at 95 ◦C, then
18 cycles of 30 s at 95 ◦C, 1 min at 65 ◦C and 7 min at 68 ◦C,
followed by 3 min at 68 ◦C. After plasmid amplification, E. coli
DH5α cells were transformed by the PCR product and colonies
were isolated on LB agar plates containing 100 µg/ml ampicillin.
To ensure that the clones used for further work contained no muta-
tions other than the intended ones, the mutated plasmid of one
clone of each mutant was prepared by miniprep and the ampD vari-
ant was sequenced on both strands. The different ampD mutants
carried by pCIP 251 derivatives were restricted with the NdeI/
BamHI enzymes and the excised fragments were cloned into
NdeI/BamHI-digested pET-9a to yield expression vectors pCIP
253–pCIP 260.
Expression in E. coli and purification of wild-type or mutant
AmpD amidases
E. coli BL 21(DE3)pLysS cells harbouring pCIP derivatives
carrying wild-type or mutant ampD genes (the sequences of
the primers can be obtained from the corresponding author on
request) were grown at 37 ◦C in LB medium supplemented
with kanamycin (50 µg/ml) and chloramphenicol (30 µg/ml) as
selection agents. The expression of the wild-type AmpD was
induced by addition of isopropyl β-D-thiogalactoside (400 µM,
final concentration) when the cell density reached a D600 value of
0.7. After 2 h of induction, the cells of a 5 l culture were harvested
by centrifugation (8300 g, 15 min, 4 ◦C), washed with 150 mM
NaCl and then resuspended in 20 mM phosphate buffer (pH 7.0)
containing 1 mM dithiothreitol (buffer A). Cell lysis was achieved
with the help of a cell disintegrator (basic Z model; Constant
Systems, Warwick, U.K.) at 4 ◦C with a pressure of 28 kp.s.i.
(193200 kPa). Benzonase (5 units/l of culture) and Pefabloc
(0.1 mg/ml, final concentration) were added to cell lysates. The
insoluble material was removed by centrifugation at 20000 g for
15 min at 4 ◦C. The supernatant was dialysed overnight against
buffer A. After dialysis, the lysate was centrifuged at 20000 g
for 15 min at 4 ◦C, microfiltered on 0.7 and 0.45 µm Millipore
filters and loaded on to a Q-Sepharose column (2.6 cm × 30 cm,
160 ml; Amersham Biosciences, Uppsala, Sweden) equilibrated
in buffer A. The column was eluted with a linear NaCl gradient
(720 ml) from 0 to 1 M. The peak fractions containing the AmpD
amidase were pooled, concentrated to 10 ml by ultrafiltration on
5000 Da-cutoff Amicon membranes and applied to a molecular
sieve column of Sephacryl S100 HR (2.6 cm × 95 cm, 500 ml;
Amersham Biosciences) equilibrated in buffer A. The fractions
containing the amidase were collected and concentrated. After
addition of 1.6 M (NH4)2SO4, the enzyme was applied to a Source
15 ISO column (1.6 cm × 10 cm, 20 ml; Amersham Biosciences).
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The AmpD enzyme was eluted with a linear gradient from
1.5 to 0 M (NH4)2SO4. The fractions containing AmpD were
collected and dialysed against 50 mM sodium phosphate buffer,
pH 7.0, and concentrated by ultrafiltration. After addition of NaN3
(1 mM, final concentration), the enzyme was stored at 4 ◦C.
The mutant AmpD proteins were overproduced and purified as
described above except that the third step was not performed.
The protein content of the column fractions was monitored
by SDS/PAGE. The AmpD concentration was determined by
measuring the absorbance of the solution at 280 nm and using
a molecular absorption coefficient of 31960 M−1 · cm−1 calculated
with the ProtParam tool (http://www.expasy.ch).
MS
The purity and molecular masses of the wild-type protein and the
AmpD substrate were determined with the help of an electrospray
mass spectrometer as described previously [17].
Metal content analysis
An aliquot (1 ml) of a 1 mg/ml solution (48 µM) of wild-type
or mutant AmpD enzyme was dialysed overnight against 250 ml
of doubly distilled water containing 10 mM Hepes, pH 7.0, at
4 ◦C. The zinc content of the enzyme was measured by ICPMS
(inductively coupled plasma MS) with the help of a Fison spectro-
meter (Fison VG Plasmaquad PQII + ; Fison, Manchester, U.K.).
The dialysis buffer contained an average of 0.15 µM Zn2+.
Preparation of the GlcNAc-anhMurNAc-tripeptide
The AmpD substrate was prepared from purified Bacillus mega-
terium peptidoglycan devoid of teichoic acid [18]. Peptidoglycan
(30 mg) in 3 ml of 100 mM ammonium acetate buffer, pH 6.5,
was incubated overnight with purified bacteriophage λ lysozyme
[19] (3%, w/v). The cleavage of the polysaccharidic chain was
followed by cleavage of the peptide bridge by the purified
Streptomyces albus G D,D-carboxypeptidase [20] (3%, w/v) in
the same buffer adjusted to pH 8.3 and supplemented with 5 mM
MgCl2. After purification by reversed-phase HPLC the molecular
mass of the substrate (GlcNAc-anhMurNAc-tripeptide; 851.6 Da)
was determined by MS as described above.
Assay of amidase activity
Amidase activity was estimated by incubating the GlcNAc-
anhMurNAc-tripeptide substrate with wild-type or mutant AmpD.
The assays were carried out in 50 mM sodium phosphate buffer,
pH 7, at 30 ◦C with substrate concentrations ranging from 18
to 240 µM and enzyme concentrations from 15 nM to 40 µM.
The reactions were stopped by a 2 min contact with boiling
water. Reaction products were separated and quantified on a
C18 reversed-phase HPLC column (Symmetry Shield RP18 5 µm,
3.9 mm × 150 mm; Waters) on a Waters Alliance 2690 System.
The column was equilibrated with 0.02% trifluoroacetic acid in
water and eluted with a linear acetonitrile gradient from 3 to 12%
over 13 min with a flow rate of 1 ml/min.
Assay of the influence of metalloprotease inhibitors and bivalent
metal cations on AmpD activity
The purified wild-type AmpD (400 nM) in buffer A was incu-
bated with metal chelators such as EDTA (5 µM), dipicolinic
acid (5 µM), 1,10-phenanthroline (5 µM), mercaptoacetic acid
(1 mM), mercaptopropionic acid (1 mM) and thiomandelic
acid (1 mM) for 30 min at 30 ◦C and the residual activity was
estimated as described above (substrate and enzyme final concen-
trations of 180 µM and 80 nM, respectively). The recovery of
AmpD activity was assayed on addition of bivalent metal cations
(ZnSO4, CuSO4, CoSO4, NiSO4, CdSO4 and MnSO4, at final
concentrations of 100 µM).
Search for AmpD inhibitors
Potential inhibitors of AmpD were 1,6-anhydro-β-D-gluco-
pyranose (100 µM; Acros Organics), 2-bromomethyl-1,3-di-
oxolane (1 M; Acros Organics), L-Ala-paranitroanilide (5 mM;
Bachem), D-Ala-paranitroanilide (5 mM; Bachem), H-Gly-
paranitroanilide (500 µM; Bachem), acetylmuramyl-L-Ala-D-
Glu-NH2 (0.1125–0.9 mM; Bachem) and anhydro-GlcNAc. The
latter was synthesized as follows: GlcNAc (2 g, 9 mmol; Sigma)
was dissolved in dry pyridine (10 ml) and cooled to 0 ◦C.
A solution of toluene-p-sulphonyl chloride (2.4 g, 12.6 mmol;
Acros Organics) in 5 ml of dry pyridine was added dropwise.
After additional stirring for 3 h at 0 ◦C, TLC analysis (dichloro-
methane/methanol, 4:1, v/v) indicated conversion of the starting
material into a predominantly tosylated form. The stirred reaction
mixture was adjusted to pH 10 by the addition of an aqueous solu-
tion of NaOH (1 M) and kept at 0 ◦C for 1 h at pH 10. TLC analysis
(dichloromethane/methanol, 3:1, v/v) of the reaction showed
conversion of tosylated compound into 1,6-anhydro-GlcNAc. The
solution was neutralized by addition of 3 M HCl and concentrated
in vacuo, diluted in pyridine (25 ml) and evaporated again. The
last step was repeated twice. To remove the traces of pyridine,
the residue was solubilized in dichloromethane (30 ml), washed
with water (20 ml), evaporated and finally dissolved in water.
The analysis of the solubilized compound by MS showed that the
1,6-anhydroGlcNAc was the major compound of the mixture.
Thermal denaturation of wild-type and mutant AmpD
Intrinsic tryptophan fluorescence was monitored using an SLM-
Aminco 8100/2 spectrometer (Spectronic Instruments, Rochester,
NY, U.S.A.), with excitation and emission wavelengths of 285
and 339 nm, respectively. Bandwidths were 4 nm for excita-
tion and 8 nm for emission. Protein concentration was 25 µg/ml.
To monitor thermal denaturation of the wild-type or mutant AmpD
enzymes, the fluorescence at 339 nm was recorded at constant
heating rates of 1 ◦C/min from 20 to 90 ◦C. The temperature
in the thermostat-controlled cuvette was monitored continuously
with a differential thermometer. Intrinsic tryptophan fluorescence
spectra of the native and denatured proteins were scanned bet-
ween 300 and 400 nm with an excitation wavelength of 285 nm.
The experimentally determined native fraction is given by
eqn (1):
Fnative = [Smes − (U + zT)]/[(N + yT) − (U + zT)] (1)
where Smes was the signal measured by fluorescence and Fnative is
the native fraction. The terms (N + yT) and (U + zT) were ne-
cessary to account for the linear decreases of the intrinsic fluore-
scence of the native and denatured states of the protein (N and U,
respectively) upon increasing the temperature.
Thermal denaturations were not reversible, so the Tm (melting
temperature) values, which are the mid-transition points, have no
thermodynamic meaning and are referred to as ‘apparent Tm’ in
the text. Tm were determined in absence or presence of 100 µM
ZnCl2.
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Molecular modelling
The start position of the complexes between the enzyme and both
small molecules were built by manually docking the substrate in
the cavity with the program Insight II (USA Biosym Technologies,
San Diego, CA, U.S.A.; http://www.accelrys.com). Thereafter,
the geometries of the complexes were optimized without any
restraint at the MM level [21] with the Amber force field [22,23]
and using the program Discover (USA Biosym Technologies;
http://www.accelrys.com) running on an SGI Indy workstation.


























The first three terms handle the internal co-ordinates of bonds,
angles and dihedrals. The fourth and fifth account for the van der
Waals and the electrostatic interactions. The final term is a hydro-
gen-bond term that augments the electrostatic description of the
hydrogen bonds. The parameters used were those describing
peptides or nucleotides [22,23].
Since the classical force field is not parameterized for descri-
bing bicyclo rings like the anhydro head, the geometry of the
anhMurNAc-tripeptide and the MurNAc-tripeptide were opti-
mized at the quantum chemistry semi-empirical AM1 level [24].
This was done to ensure that the starting geometry of the substrates
was reliable. The program used was Gaussian98 (revision
A6; Gaussian, Pittsburgh, PA, U.S.A.; http://www.gaussian.com)
running on an eight-processor DEC-alpha 8400. As to the elec-
trostatic terms for the non-bonded interactions of the MM field, the
net charges used for the substrates were determined at the quantum
chemistry level, at the restricted Hartree–Fock level [25] with
the 6-31G basis set [26,27]. A dynamical study was performed
with the program Discover. The geometry optimizations were
performed without water, a dielectric constant of 2 was chosen
and the threshold for convergence was taken to be the maximum
force fixed at 0.02 kcal · mol−1 · Å−1 (1 kcal = 4.184 kJ). In the
dynamical calculations which considered a layer of about 1100
water molecules, the dielectric constant was taken as 1, the
temperature was fixed at 300 K and the time of the simulation
was 30 ps following a pre-equilibration step of 30 ps at 300 K.
RESULTS
Modelling (NMR results compared with MM results)
The structure obtained by NMR [9] was optimized at the MM
level before docking and molecular dynamics (Table 1). It must
be emphasized here that in both the NMR and the MM structures,
the external His side chains in contact with the solvent, such as
that of His-18, were considered as protonated, since the NMR
experiments were performed at pH 5.5.
The MM distances between the zinc and either the His or Asp
ligands are in better agreement with those observed in the crystal
structures of other zinc hydrolases, for instance in entries 3TMN,
1LBU, 1C7K and 1G12 [28–31] of the Protein Data Bank
(now maintained by the Research Collaboratory for Structural




Zn–Nδ1 (His-34) 2.23 2.33
Zn–Nδ1 (His-154) 2.23 2.40
Zn–Oδ1 (Asp-164) 2.27 2.02
Zn–Oδ2 (Asp-164) 2.12 2.05
Zn–Oε1 (Glu-116) 6.47 6.89
Nε2 (His-34)–Oε1 (Glu-116) 2.66 2.72
Bioinformatics; http://www.rcsb.org/pdb/index.html) in which
the Zn–O(Asp) are always shorter than the Zn–N(His) distances.
It appeared that the zinc could also be co-ordinated by the oxygen
of the Asn-35 backbone.
Optimization of the complexes
The amidase substrate molecules have been subdivided into a
head, a scissile bond and a tail (Figure 2). The head is either an
N-acetyl-anhydromuramyl (Figure 2B) or an N-acetylmuramyl
(Figure 2A) residue, the scissile bond is that cleaved by the AmpD
amidase and the tail the tripeptide stem of the peptidoglycan. Two
complexes with the anhydro head and two with the MurNAc head
were built by docking the small molecule into the enzyme active
site. The head was positioned inside the cleft and the oxygen
of the scissile bond was oriented toward the zinc cation. The
tail was oriented either towards Lys-162 [anhydroMurNAc_1
complex (Figure 3A) and MurNAc_1 complex], or towards
Arg-22 and Asn-109 [anhydroMurNAc_2 complex (Figure 3B)
and MurNAc_2 complex], both residues lying on the solvent-
accessible surface of the enzyme. The results of the MM geometry
optimizations of the four complexes are available on request and
described below. Several hydrophobic residues are involved in
the interactions with the head of the substrate in both types of
complex: Pro-39, Val-72, Ile-67, Leu-51, Ile-56 and possibly
also the neighbouring Pro-40, Ile-36 and Leu-38. However, we
do not understand why the anhMurNAc-tripeptide behaves as a
substrate while the MurNAc-tripeptide does not, since they both
exhibit favourable interactions with the cavity. The difference
could be due to the existence in MurNAc-tripeptide of two
additional rotatable OH groups (the C6 and C1 hydroxyls), whose
hydrogens decrease the influence of the oxygens. The interaction
distances in optimized structures reflect a static situation. When
the temperature effect is taken into account, the motions of these
groups can most probably be a destabilizing factor.
Dynamical calculation results
The dynamics study was performed on solvated systems. The
chosen optimized complexes were solvated in two steps. A first
layer of 76 (for the anhydroMurNAc) or 63 (for the MurNAc)
water molecules was created around the substrate, in the sol-
vent-accessible area. The second layer is made up of 1057
(anhydroMurNAc) or 1033 (MurNAc) water molecules distri-
buted around the whole complex. The water bath was provided
by the Insight II program. A rough optimization of the solvent
shell was performed until the maximum force on these molecules
was lower than 1 kcal · mol−1 · Å−1 and a first dynamical run was
done at 300 K for 30 ps with a decreasing restraint from 1000 to
200 kcal · mol−1 · Å−2 on all the water oxygens. No other restraints
were imposed. The final dynamical run described below starts
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Figure 2 Structure of the MurNAc-tripeptide (A) and anhMurNAc-tripeptide (B) substrates
R = H or GlcNAc. In (B), the O#1 is defined as the anhydro oxygen and the O#2 as the pyrano oxygen.
from the solvated complex obtained in the first dynamical run for
which the potential energy was the lowest. It also lasts 30 ps at
300 K. In order to avoid water evaporation during the process, a
restraint of 200 kcal · mol−1 · Å−2 was maintained on the oxygens
of the water molecules in the second layer.
Only one pair of complexes was at first considered, anhydro-
MurNAc_1 and MurNAc_1. Then, in order to eliminate the proton
on His-18, which interacts strongly with the anhydro head in the
course of the dynamics (the smallest distance between the oxygens
of the head and the His-18 side chain varies between 2.5 and
4.3 Å), two other complexes were considered in which His-18 was
not protonated. These complexes, named anhydroMurNAc_3 and
MurNAc_3, are built from anhydroMurNAc_1 and MurNAc_1.
During the course of the dynamics, two water molecules, W1 and
W2, are found to approach the zinc. The following conclusions
derive from these results. If one considers that the interaction
between Zn2+ and the negative head of Asp-164 is strong, one
can relate short distances (<2 Å) and a small variation during
the dynamics (≈0.5 Å) with a strong interaction. Thus strong
interactions are maintained during the dynamics between Zn2+ and
(i) the oxygen of the scissile bond in all cases, (ii) the backbone
oxygen of Asn-35 in three cases out of four, (iii) W1 in three cases
and (iv) W2 in two cases.
However, His-34 and His-154 do not seem to remain good zinc
ligands when the substrate is in the cavity. Moreover, the result
is dependent on the dynamics considered. Favourable oxygen–
hydrogen interactions between the substrate head and Ile-67, Leu-
51 and Val-72 are found for anhydroMurNAc and MurNAc. More
precisely, the distances O#1–Cδ1(Leu-51) for anhydroMurNAc
and MurNAc and their ranges of variation are similar. By contrast,
the distances O#2–Cβ(Ile-67) and O#1–Cγ (Pro-39) are shorter
for anhydroMurNAc than for MurNAc and their variations are
also smaller, denoting a stronger interaction with the anhydro
compound. Interestingly, the distance O#1–Cδ1(Ile-67) is shorter
for MurNAc but its variation is larger. As a general observation,
all the distance variations are either similar, or larger in the case
of MurNAc, as compared with the anhydro form. Furthermore,
it appears that the C6 and C1 hydroxyl hydrogens of MurNAc
undergo unfavourable interactions with Ile-67 and to a lesser
extent with Leu-51. In the case of Val-72, the dynamics results
for anhydroMurNAc_3 present two distinct phases, the first one
corresponding to 0–16.2 ps where the considered distance is larger
than 4 Å, and the second one extending from 16.4 to 30 ps during
which this distance remains rather short. From all these results,
it seems that the anhydro head is maintained more firmly in the
cavity by the hydrophobic side chain residues than is MurNAc.
One reasons for this could be the unfavourable role of the C6 and
C1 hydroxyl hydrogens of MurNAc.
Structural localization of the different mutations
To map the active site of AmpD amidase, we introduced eight
point mutations at six different amino acid positions in the
AmpD polypeptide chain. Four of them will affect binding of
the zinc ion: H34A, H154A, H154N and D164A. According
to the three-dimensional models (Figure 3), Tyr-63 is pointing into
the active site and might be involved in the catalytic mechanism,
whereas Glu-116 could be in interaction with His-34 and could be
important to adequately orient the imidazole ring of the histidine
side chain to chelate the metal ion.
Overexpression and purification of wild-type and mutant
AmpD amidases
After production of the different enzymes in E. coli BL21
(DE3)pLysS and their purification to protein homogeneity, a yield
of 16 mg of wild-type AmpD/l of culture was obtained whereas
those for AmpD mutants ranged from 8 mg/l for D164A to 36 mg/l
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Figure 3 Stereo views of the two optimized models of the AmpD–substrate complexes
(A) AnhydroMurNAc_1 complex with the tail oriented towards Lys-162; (B) anhydroMurNAc_2 complex with the tail oriented towards Arg-22 and Asn-109. The polypeptide backbone is drawn in
green. The zinc atom is depicted as a purple sphere with the side chains of the co-ordinating residues His-34, His-154, Asp-164 and the residues Tyr-63, Glu-116, Lys-162 drawn in bold. Red and
blue spheres mark the oxygen and nitrogen atoms of these residues, respectively. The substrate 1,6-anhydroMurNAc-L-alanyl-γ -D-glutamyl-meso-diaminopimelic acid is drawn as an orange line.
for H34A. After the first two chromatographic steps, the enzymes
were 95% pure and the third step on the isopropyl Source column
was performed to eliminate a contaminant protease and separate
the wild-type AmpD isoforms. Indeed, on this hydrophobic
column, the wild-type AmpD was eluted in two peaks exhibiting
the same apparent molecular mass value on SDS/PAGE. The MS
analysis showed that the two peaks were a mixture of the two
polypeptide chains of 20847 Da (form I) and 20357 Da (form
II). This difference between the two forms (490 Da) corresponds
to deletion of the last four C-terminal residues of AmpD (Lys-
Glu-Met-Thr; 489 Da). The molecular mass of form I matched
that of the full-length wild-type AmpD (20847.17 Da). In the first
and second peaks the ratios of form I/form II were 3:1 and 10:1,
respectively. The NMR and kinetic studies revealed no difference
between the enzymes in the two peaks (results not shown). For
the AmpD mutants, the third chromatographic step was omitted.
Characterization of wild-type AmpD and inhibition
of the enzyme activity
With no zinc ion added to the dialysis buffer (10 mM Hepes,
pH 7.0, and a residual zinc concentration lower than 0.15 µM),
the wild-type enzyme contained 0.7 +− 0.2 mol of zinc/mol of
protein. After addition of 10 and 100 µM of ZnCl2 to the dialysis
buffer, the metal contents of AmpD enzyme increased to 1.3 and
3.7 mol/mol of protein, respectively. Inhibition of amidase activity
by metal chelators was carried out by incubating the wild-type
enzyme (final concentration, 80 nM) with EDTA, dipicolinic acid
or 1,10-phenanthroline (final concentrations, 5 µM). In each case
the enzyme was completely inhibited after 30 min and the activity
was restored by addition of 100 µM (final concentration) ZnSO4.
Under the same conditions, CuSO4, CoSO4, NiSO4, CdSO4 and
MnSO4 did not restore even partial amidase activity.
The kcat/Km value of the hydrolysis of GlucNAc-anhMurNAc-
tripeptide was 20000 +− 5000 M−1 · s−1. Separate values for kcat and
Km could not be obtained because the Km value for this substrate is
greater than 0.8 mM. Indeed, at this concentration substrate uti-
lization was first order.
No inhibition of amidase activity was observed with compounds
containing a 1,3-dioxolane ring as in the anhydroMurNAc, such as
1,6-anhydro-β-D-glucopyranose (final concentration, 100 µM),
2-bromomethyl-1,3-dioxolane (1 M) and anhydro-GlcNAc (this
study). As suggested by molecular modelling, MurNAc-L-Ala-
D-Gln was a competitive inhibitor with a K i value of 190 +−
50 µM, estimated by incubating the enzyme with inhibitor con-
centrations ranging from 0.1 to 0.9 mM. Wild-type AmpD was
also assayed for amidase activity by incubating the enzyme with
L-Ala-paranitroanilide (5 mM), D-Ala-paranitroanilide (5 mM)
and H-Gly-paranitroanilide (500 µM). Neither amidase activity
nor inhibition was detected with these compounds.
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Table 2 Properties of the AmpD mutants
The zinc ion content was determined by inductively coupled plasma MS in 10 mM Hepes at
pH 7.0. The free zinc concentration was 0.15 µM. The kinetic parameters for the wild-type
enzyme and the mutants were obtained in 20 mM phosphate at pH 7.0 and 30 ◦C. Relative
kcat/K m is shown relative to the wild-type value. [E], enzyme concentration.
Enzyme [Zn2+]/[E] kcat/K m (M−1 · s−1) Relative kcat/K m (%)
Wild-type 0.7 +− 0.2 20 000 +− 5000 100
H34A 0.2 +− 0.1 < 1 < 0.2
Y63F 0.4 +− 0.1 3100 +− 300 16
E116A 0.3 +− 0.1 < 1 < 0.2
H154A 0.1 +− 0.05 2 +− 0.3 < 0.2
H154N 0.6 +− 0.2 15 000 +− 3000 76
K162H 0.5 +− 0.2 140 +− 14 0.7
K162Q 0.6 +− 0.2 33 +− 4 0.2
D164A 0.2 +− 0.1 < 1 < 0.2
Metal content of AmpD mutants
With no zinc added to the buffer, the zinc-ion content of the AmpD
mutants is summarized in Table 2. Compared with the value of
the wild-type enzyme (0.7 mol of zinc/mol of protein), the AmpD
mutants fell into three categories: (i) the H154N, K162H and
K162Q mutants exhibited zinc contents similar to that of wild-
type AmpD; (ii) the Y63F and E116A mutants had slightly
lower values in the range 0.3–0.4 mol of zinc/mol of protein and
(iii) the H34A, H154A and D164A mutants did not bind more
than 0.2 equivalents of zinc.
Thermal denaturation followed by fluorescence
AmpD has four tryptophan residues, which dominate the fluore-
scence spectrum, seven tyrosines and seven phenylalanines, which
make small contributions to the overall intrinsic protein fluo-
rescence. Using an excitation wavelength of 285 nm, the
fluorescence emission spectra of the AmpD mutants were
superimposable on to that of the wild-type enzyme (results not
shown). As the subtle structural differences that might be expected
could therefore not be detected by UV fluorescence, the thermal
stability of the different enzymes was determined by the analysis
of their thermal unfolding. A rigorous thermodynamic analysis of
Figure 4 Thermal denaturation followed by fluorescence
(A) Wild-type AmpD () and the H34A (), H154A () and D164A () mutants. (B) Wild-type AmpD () and the Y63F (), E116A () and K162H () mutants. K162Q and H154N mutants
(not shown) followed the same profile as the wild type.
Table 3 Tm values of wild-type and mutant AmpDs with and without ZnCl2
(100 µM)
AmpD Tm (◦C) Tm(WT−mutant) (◦C) Tm(100 µM Zn−0 µM Zn) (◦C)
Wild-type (WT) 59.8 – − 0.1
Wild-type + Zn2+ 59.7
H34A 50.9 − 8.9 − 15.9
H34A + Zn2+ 35
Y63F 61.1 + 1.3 − 6.4
Y63F + Zn2+ 54.7
E116A 66.3 + 6.5 − 4.1
E116A + Zn2+ 62.2
H154A 55.5 − 4.3 − 3.2
H154A + Zn2+ 52.3
H154N 59.6 − 0.2 − 2.4
H154N + Zn2+ 57.2
K162H 62.2 + 2.4 − 6.1
K162H + Zn2+ 56.1
K162Q 60 + 0.2 − 1.5
K162Q + Zn2+ 58.5
D164A 45.6 − 14.2 − 6.2
D164A + Zn2+ 39.4
thermal unfolding curves from modified and wild-type AmpD
was not possible due to the irreversibility of the phenomenon.
However, thermal unfolding curves established by recording the
decrease of the fluorescence at 339 nm induced by a temperature
increase at a rate of 1 ◦C/min were used to determine the apparent
Tm values (Table 3 and Figure 4).
Regarding their relative intrinsic stabilities against temperature,
the most significant differences, when compared with the wild-
type enzyme (Tm = 59.8 ◦C), were observed when zinc ligands
were substituted with alanine [H34A, Tm(WT−mutant) =−8.9 ◦C;
H154A, Tm(WT−mutant) = − 4.3 ◦C; D164, Tm(WT−mutant) =
−14.2 ◦C]. The H154N mutation, which modified the nature
of the zinc ligand but retained its ability to form a complex with
the metal ion, did not significantly modify the Tm value. The
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Y63F, E116A and K162H mutants were more stable than the wild-
type enzyme, whereas the K162Q mutant was as stable as the
native AmpD. The addition of an excess of ZnCl2 (100 µM,
final concentration) had no effect on the wild-type enzyme, but
destabilized all the modified enzymes (Table 3). The maximum
decrease in Tm was obtained for H34A mutant with a Tm of
− 15.9 ◦C between 0 (<0.15 µM) and 100 µM Zn2+.
Kinetic studies
The catalytic efficiencies of the AmpD mutants against GlcNAc-
anhMurNAc-tripeptide were compared with that of the wild-
type enzyme at pH 7.0 (kcat/Km = 20 × 103 M−1 · s−1; Table 2).
Substitutions of the residues of the zinc-binding site with an
alanine (H34A, H154A and D164A) resulted in inactivation of
the enzyme (kcat/Km 2 M−1 · s−1), which can be attributed to the
loss of the active-site zinc ion (Table 2).
The zinc-dependence of the catalytic efficiencies of the wild-
type enzyme and the H154A mutant was studied. For the
wild-type AmpD, high Zn2+ concentrations up to 1 M did not
modify the kinetic parameters whereas the kcat/Km of the H154A
mutant increased to reach a maximum value of 13 M−1 · s−1.
On the other hand, the H154N substitution was designed to
modify the nature of the zinc ligand while maintaining the capacity
of the side chain to bind zinc. As postulated, the H154N mutant
retained both its capacity to bind the zinc ion and good amidase
activity.
The E116A mutant was totally inactive. The loss of its activity
was attributed to its inability to bind zinc, although this residue
does not interact directly with the metal ion.
Among the potential catalytic residues within the cleft which
could be involved in the acid–base catalysis, Tyr-63 is well posi-
tioned and may have a critical role. By analogy with T7 lysozyme,
Lys-162 was also considered, although it is not close to the
active site. The results of site-directed mutagenesis support the
idea that these two residues are important for amidase activity
without affecting the ability of the mutants to bind the zinc ion
(Table 2). The Y63F replacement was performed both to modify
the H-bond-forming side chain of Tyr-63 and to assess the role
of the tyrosine hydroxyl group in the acid–base catalysis. The
Y63F mutation reduced the amidase activity by a factor 6. A
part of this loss can be related to the level of zinc binding in
the cavity. This seems to demonstrate that Tyr-63 is not involved
in an acid–base mechanism. The increase in activation energy
for the formation of the transition state complex [(G∗)] by
replacing Tyr-63 with Phe was estimated to be 4.6 kJ · mol−1, using
(G∗) = − RTln[(kcat/Km)mutant/(kcat/Km)WT], indicating that Tyr-
63 might supply a poor H-bond during the catalytic process.
The replacement of Lys-162 with a His residue would confer
a characteristic pH dependence to the kinetic parameters of
the enzyme. Indeed, if the pK of the imidazole group is not
perturbed by the protein environment, detectable effects should
be recorded in a pH interval between 7 and 5.5. For the K162H
mutant, a 4-fold decrease of the kcat/Km value was observed when
the pH was decreased from 7 to 5.8. With the wild-type en-
zyme, the same result was obtained. The second mutation
(K162Q) was designed to completely eliminate the proton-
exchange ability and the net positive charge of the side chain.
The K162H and K162Q mutants exhibited, respectively, 0.7 and
0.2% of the wild-type activity. The increases in activation energy
[(G∗)] for the formation of the transition complex when
replacing Lys-162 with His and Gln were estimated to be 12
and 16 kJ · mol−1 respectively, highlighting the importance of the
Lys-162 side chain for the positioning of the ligand.
DISCUSSION
In the present work, we combined molecular dynamics and
site-directed mutagenesis to study the catalytic mechanism of
the AmpD amidase. The amidase activity was assayed with the
GlcNAc-anhMurNAc-tripeptide, which is the compound
generated by the autolytic system and transported into the cell
by AmpG during the peptidoglycan-recycling process. In the
cytoplasm of E. coli HfrH cells in which the ampD gene
has been inactivated, the major accumulated compound is the
anhMurNAc-tripeptide, generated by the action of the β-N-
acetylglucosaminidase (NagZ) on the disaccharide anhMurNAc-
tripeptide. Jacobs et al. [5] estimated that the Km value was
lower than 150 µM and that the kcat value was 30 +− 10 s−1 for
the anhMurNAc-tripeptide. By contrast, our results show that the
Km value for the disaccharide anhMurNAc-tripeptide is greater
than 0.8 mM, yielding a kcat/Km value of 20000 M−1 · s−1. The
comparison of the kcat/Km values for the two anhydro substrates
suggests that, in the cytoplasm, the anhMurNAc-tripeptide
is hydrolysed more rapidly than the GlcNAc-anhMurNAc-
tripeptide. Consequently, the hydrolysis of the disaccharide
anhMurNAc-tripeptide by NagZ might take place before the
action of AmpD.
Purified wild-type AmpD amidase binds 1 mol of Zn2+/mol
of protein and the metal ion is required for amidase activity. In
agreement with this interpretation, 1,10-phenanthroline or EDTA,
strong Zn2+ chelators, inactivated the amidase activity, which was
restored by adding Zn2+. Clearly, the naturally occurring Zn2+ is
essential for the amidase activity of AmpD. We showed that Cu2+,
Co2+, Ni2+, Cd2+ and Mn2+ could not activate the enzyme.
Based on the three-dimensional NMR structure of AmpD, the
replacement of the three side chains (His-34, His-154 and Asp-
164) involved in chelation of the zinc ion with alanine eliminated
the amidase activity and the binding of the Zn2+ to the protein. The
H154N substitution, which conserved the capacity of the side
chain to bind the metal ion, produced a fully active mutant
enzyme and confirmed the role of the three side chains cited
above as the zinc ligands. In the bottom of the cavity, Glu-116
in close interaction with the imidazole ring of His-34 seems to
be important for the good orientation of the histidine side chain
to chelate the zinc ion. Indeed, the E116A mutant is completely
inactive and has lost its zinc ion exactly as in the case of the
substitutions of the zinc ligands by alanine. However, the large
Tm for this mutant (Tm = + 6.5 ◦C; Table 3) might suggest a
substantial structural rearrangement and thus a different role for
Glu-116.
The analysis of the docking of the anhMurNAc-tripeptide and
the corresponding MurNAc compound into the AmpD catalytic
cavity by molecular dynamics showed that the compounds could
form stable complexes with the enzyme. It is not clear why AmpD
is specific for the presence of the anhydro function borne by
the MurNAc moiety of the substrate. Nevertheless, our results
suggest that in the case of the MurNAc-tripeptide the orientation
of the compound in the catalytic cavity might give rise to a
catalytically unproductive complex. This hypothesis is consistent
with the inhibition of AmpD amidase by MurNAc-L-Ala-D-Gln
(K i = 190 +− 50 µM). The results of the molecular dynamics seem
to pinpoint an important mobility of the Zn2+ ligands during
the formation of the Henri–Michaelis complex. This observation
could be important for the catalytic mechanism. Two other
residues, Tyr-63 and Lys-162, pinpointed by docking experiments,
could be involved in the binding of the substrate in the catalytic
cavity. In addition, the hydroxyl group of Tyr-63 remains close
to the scissile peptide bond during the dynamics performed
with the anhydro compound and could be involved in catalysis,
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Scheme 1 Mechanism proposed in [10] for catalysis by T7 lysozyme
This mechanism is based on the experimental T7 lysozyme observation that the T7 Tyr-46 hydroxyl superimposes on to the Glu-270 of carboxypeptidase A. Note, however, that there is no direct
experimental proof for the existence of a dissociated tyrosine phenol group. R1, MurNAc; R2, L-alanyl-γ -D-glutamyl-meso-diaminopimelyl-D-alanine; E · S, Michaelis–Menten complex; [E-S]‡,
tetrahedral intermediate; Ps, products.
although in a minor way. The AmpD Y63F mutant remained
16% active compared with the wild-type enzyme, which might
indicate that the Tyr-63 side chain is involved in substrate binding
rather than catalysis. As predicted by molecular modelling, the
Lys-162 side chain could be important for the binding of
the substrate, since it interacts strongly with the carboxylate
tail (Figure 3A) of the peptide. Both the K162H and K162Q
mutants retained a very low activity, underlining the importance
of a positive charge in this position. It was not possible to clearly
test the possible effects of a positive His-162 side chain, since the
enzymes precipitated at pH 5.5 and below. The superimposition
of the equivalent zinc ligands in AmpD and T7 lysozyme (Fig-
ure 1) allows a comparison of their catalytic sites and suggests an
important difference between the catalytic mechanisms of the two
amidases. This difference is that the Lys-128 and Tyr-46 residues
of T7 lysozyme (Scheme 1), which are suitably positioned to play
the roles of acid–base catalysts in the reaction [10], are not present
in the AmpD catalytic cavity. Tyr-63 in AmpD roughly points
towards a position at the top of the cavity similar to that of Lys-128
in T7, but they are not oriented in the same way at all. Moreover,
no residue occupying a position equivalent to that of Tyr-46 in the
T7 amidase can be found in the AmpD catalytic site. In AmpD,
Glu-116 cannot be equivalent to Tyr-46 in the T7 amidase. In-
deed, Glu-116 is buried in the bottom of the cavity and too far away
from the scissile amide bond, whereas Tyr-46 points directly into
the T7 lysozyme catalytic cavity. Thus at this stage of our study, no
amino acid side chain has been found in the AmpD active site that
could play the role of a general base catalyst. For this reason, the
AmpD catalytic mechanism remains obscure. Nevertheless, there
is little doubt that the zinc ion acts as an electrophilic catalyst.
The main catalytic role of the enzyme could be to enhance the pep-
tide bond reactivity itself by polarizing the C=O bond and pro-
viding an sp3 character to the carbon and, consequently,
decreasing the π delocalization on the peptide bond, leading to a
larger N–C bond length and an easier pyramidalization or, in an
equivalent way, a greater basicity of the nitrogen. Thus both the
carbon and nitrogen of the peptide bond become more reactive
towards water attack. This water molecule could be activated by
the zinc ion itself or by another mechanism. This question remains
open.
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